|
End-of-day quote
Nasdaq
|
||
| - | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Reinhard Kandera
DFI | Director of Finance/CFO | 56 | - |
Franck Grimaud
PRN | Corporate Officer/Principal | 59 | 01/12/2015 |
Robert C. Seid
PRN | Corporate Officer/Principal | - | 01/08/2008 |
| Director | Title | Age | Since |
|---|---|---|---|
F. Weller Meyer
BRD | Director/Board Member | 83 | 01/01/2006 |
David Lawrence
BRD | Director/Board Member | 63 | 01/11/2017 |
| Director/Board Member | 87 | 05/07/2006 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.67% | -4.78% | +36.76% | -4.34% | 7.93TCr | |
| -0.90% | +2.39% | -19.06% | -35.50% | 5.92TCr | |
| -3.35% | -4.92% | +472.81% | +18.97% | 5.51TCr | |
| -6.78% | -4.19% | -3.45% | +28.35% | 4.99TCr | |
| -2.43% | -2.35% | +8.33% | +160.40% | 4.79TCr | |
| -1.35% | +0.79% | +65.25% | -18.47% | 3.23TCr | |
| -2.64% | -2.69% | +46.99% | +92.55% | 2.52TCr | |
| -0.09% | +4.98% | +11.00% | +199.86% | 2.39TCr | |
| -0.34% | +1.35% | +62.33% | +122.21% | 1.69TCr | |
| Average | -2.17% | -1.20% | +75.66% | +62.67% | 4.33TCr | |
| Weighted average by Cap. | -2.42% | -2.05% | +83.85% | +41.75% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
